Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the treatment of type 2 diabetes. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://deannabksf174778.bloguetechno.com/trelaglutide-exploring-a-new-therapy-for-chronic-diseases-75193888